Ro
Ro is a US direct-to-patient telehealth company. It sells online consultations, prescriptions and home-delivered medication for weight loss, sexual health, hair loss and women's health.
Ro runs a vertically integrated platform of telehealth, labs and its own pharmacy, covering diagnosis, medication delivery and ongoing care. It sells directly to consumers, mainly through subscription-style telehealth visits and recurring medication fulfillment, including GLP-1 weight-loss programs. It was founded in 2017 and raised about $1.03B in total. That includes a $500M Series D in March 2021 at a $5B valuation and a 2022 extension at roughly $7B. Sacra estimates 2024 annualized revenue of about $598M, up 66% from about $360M in 2023. Ro is a healthcare company, not an AI company.
